XII Medical, a Union City, CA-based clinical-stage medical technology company, raised $45M in Seris B funding.
The round was led by Omega Funds and joined by new investor Intuitive Ventures. Existing investors also participated, including founding investor Cleveland Clinic, Ajax Health, Longview Ventures (an affiliate of Broadview Ventures), Aperture Venture Partners, JobsOhio Growth Capital Fund and an undisclosed strategic investor
The company intends to use the funds to further product and clinical development.
Led by CEO Garrett Schwab, Founded in 2017, XII Medical is a clinical-stage medical technology company improving the treatment of obstructive sleep apnea via a patient-centric neuromodulation therapy designed to enhance quality of life for the millions of people suffering from it.
Its platform is limited to investigational use and is not available for sale.
FinSMEs
21/08/2024